Intraorifice Sealing Ability of Different Materials in Endodontically Treated Teeth
Intraorifice Sealing Ability of Different Materials in Endodontically Treated Teeth
Intraorifice Sealing Ability of Different Materials in Endodontically Treated Teeth
1
BDS, BDS, Graduate in Dentistry, Department of Dental Pathology and Therapeutics, School of Dentistry, University of
Granada (Spain)
DDS, PhD, Contracted Professor, Department of Dental Pathology and Therapeutics, School of Dentistry, University of Granada
(Spain)
DDS, MD, PhD, Associate Professor, Department of Dental Pathology and Therapeutics, School of Dentistry, University of
Granada (Spain)
2
PhD, Clinical Analysis Service, Hospital Virgen de las Nieves, Granada (Spain)
Correspondence:
Department of Dental Pathology and Therapeutics,
School of Dentistry, University of Granada, Spain,
Campus de Cartuja, Bailón-Sánchez ME, González-Castillo S, González-Rodríguez MP,
Colegio Maximo s/n, Poyatos-Martínez R, Ferrer-Luque CM. Intraorifice sealing ability of dif-
18071 Granada, Spain ferent materials in endodontically treated teeth. Med Oral Patol Oral Cir
[email protected] Bucal. 2011 Jan 1;16 (1):e105-9.
http://www.medicinaoral.com/medoralfree01/v16i1/medoralv16i1p105.pdf
Abstract
Objectives: To evaluate Cavit™ G, ProRoot™ MTA and Tetric® EvoFlow as intraorifice barriers to prevent coro-
nal microleakage in root canal treatment.
Study Design: Forty-two human single rooted teeth were divided randomly in three experimental groups of 10
specimens each and two control groups. The experimental groups were prepared with hand instrumentation and
cold lateral condensed technique of the gutta-percha. Four millimetres of coronal gutta-percha were removed and
replaced by one of the following filling materials: Cavit™ G, Tetric® EvoFlow or ProRoot™ MTA. In the experi-
mental groups, leakage was measured by the concentration of leaked glucose in the apical reservoir at 1, 7, 30,
and 45 days, using the enzymatic glucose oxidase method. Data were analyzed by means of Mann-Whitney U and
Kruskal-Wallis tests at α=0.05.
Results: The glucose penetration results of three experimental groups increased gradually over time. No signifi-
cant differences were found among groups at 24 hours and 1 week. At thirty and forty-five days, Cavit™ and
Tetric® EvoFlow values were significantly different (p=0.007 and p=0.023, respectively).
Conclusions: The sealing ability of the Cavit™ G, ProRoot™ MTA and Tetric® EvoFlow used as intraorifice ma-
terials tends to be similar over time.
Key words: Cavit™ G, coronal microleakage, glucose penetration model, intraorifice barrier, Tetric® EvoFlow,
ProRoot™ MTA.
e105
Med Oral Patol Oral Cir Bucal. 2011 Jan 1;16 (1):e105-9. Topical corticoids in oral pathology
e106
Med Oral Patol Oral Cir Bucal. 2011 Jan 1;16 (1):e105-9. Topical corticoids in oral pathology
until the cavity was filled, after which it was cured with wise comparisons of the mean glucose leakage values.
a visible light activator for 30 seconds. Each root was The level of statistical significance was set at p<0.05.
placed in a coded container and stored at humidity for All statistical analyses were performed using SPSS 15.0
48 hours to allow the materials to set. software (SPSS Inc, Chicago, IL).
Glucose penetration model
The roots (thirty experimental teeth and twelve controls) Results
were mounted on a glucose leakage modified model (12). The microleakage results are presented in Table 1 and
Then, 100 μl of solution was drawn from a glass bottle Fig. 1. The amount of glucose penetration of the three
using a micropipette immediately afterwards, and at experimental groups increased gradually over time.
24 hours, 7, 30 and 45 days. The same amount of fresh The lowest glucose leakage that the current procedure
sterile water was added to the glass bottle to maintain is able to detect is 2mg/dL (0.11 mmol L-1), lower read-
a constant volume of 2 mL. The sample was then ana- ings were not reported (missing values).
lysed using a Glucose kit (Gluco-quant Glucose/HK, At the first day, the leaked glucose values ranged be-
Roche/Hitachi 917/ACN 549. Roche Diagnostics, Basel, tween 2.75 mmol/L-1 for Cavit™ G and 3.38 mmol/L-1
Switzerland), in a Modular System Autoanalyzer (Ro- for ProRoot™ MTA. At the end of the evaluation pe-
che Diagnostics, Basel, Switzerland), at a wavelength riod, the microleakage values detected with the three
of 340 nm. The concentrations of the glucose were ex- intraorifice sealing materials were 8.26 mmol/L-1
pressed in mmol L-1 at each time interval. (Cavit™ G), 8.44 mmol/L-1 (Tetric® EvoFlow) and 8.61
Statistical analysis mmol/L-1 (ProRoot™ MTA). No significant differences
Mean and standard deviations were determined for each were found among materials at 24 hours and 1 week. At
group. The Shapiro-Wilk test was used to check the nor- thirty and forty-five days, the values of glucose penetra-
mality of data distribution. As the results for each group tion differed significantly among the three groups: for
did not follow a normal distribution, the variables were both evaluation times, Cavit™ G and Tetric® EvoFlow
analyzed using a nonparametric test. After Kruskal- results showed significant differences (p=0.007 and
Wallis test the Mann-Whitney U test was used for pair- p=0.023, respectively).
Table 1. Penetration glucose values in mmol L-1 at different time periods (mean and
standard deviations).
Glucose leakage
e107
Med Oral Patol Oral Cir Bucal. 2011 Jan 1;16 (1):e105-9. Topical corticoids in oral pathology
e108
Med Oral Patol Oral Cir Bucal. 2011 Jan 1;16 (1):e105-9. Topical corticoids in oral pathology
e109